ClinicalTrials.gov
ClinicalTrials.gov Menu

Plasma Pharmacokinetics of Alkylresorcinol Metabolites; New Candidate Biomarkers for Whole Grain Rye and Wheat Intake (Rye-kinetics)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00953836
Recruitment Status : Completed
First Posted : August 6, 2009
Last Update Posted : August 6, 2009
Sponsor:
Collaborators:
Samfundet Folkhälsan
Sigrid Jusélius Foundation
Information provided by:
Helsinki University

Brief Summary:
The purpose of this study is to investigate the kinetics of two known alkylresorcinol metabolites in human subjects after intake of high-fiber rye bread. Whole grain rye is the most abundant source of alkylresorcinols.

Condition or disease
Kinetics of Alkylresorcinol Metabolites

Study Type : Observational
Actual Enrollment : 15 participants
Time Perspective: Prospective
Official Title: Kinetic Study of Two Known Alkylresorcinol Metabolites in Human Subjects After the Intake of Rye Fiber, the Most Abundant Source of Alkylresorcinols in Diet.
Study Start Date : March 2009
Actual Primary Completion Date : April 2009
Actual Study Completion Date : May 2009




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
healthy, free-living females and males
Criteria

Inclusion Criteria:

  • Healthy, volunteer

Exclusion Criteria:

  • Hemoglobin below 125 mmol/L in females and below 135 mmol/L in males use of antibiotics within 3 months before entering the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00953836


Locations
Finland
Folkhälsan Research Center
Helsinki, Finland, 00250
Sponsors and Collaborators
Helsinki University
Samfundet Folkhälsan
Sigrid Jusélius Foundation
Investigators
Study Director: Matti J Tikkanen, M.D., prof. Department of Medicine, University of Helsinki, Helsinki, Finland

ClinicalTrials.gov Identifier: NCT00953836     History of Changes
Other Study ID Numbers: 22/13/03/00/09
First Posted: August 6, 2009    Key Record Dates
Last Update Posted: August 6, 2009
Last Verified: August 2009

Keywords provided by Helsinki University:
kinetics
alkylresorcinol metabolites
rye fiber